1-4 of 4
Jon Karch
Close
Sort by
Journal Articles

Long Term Survival After Sirolimus Based Non-Ablative Alternative Donor Transplantation.

Jon Karch, BSc, Eric Schaefer, M.A., W. Chritopher Ehmann, MD, Michelle Carraher, BA, Giampaolo Talamo, MD, Witold B Rybka, MD, David F. Claxton, M.D.
Journal: Blood
Blood (2009) 114 (22): 1212.
https://doi.org/10.1182/blood.V114.22.1212.1212
Published: 2009
Journal Articles

Treatment of Primary CNS Lymphoma with Induction High-Dose Methotrexate, Temozolomide, Rituximab Followed by Consolidation Cytarabine/Etoposide: A Pilot Study with Biomarker Analysis.

Samar Issa, MD, Arthur Shen, B.S., Jon Karch, B.S., Cigall Kadoch, B.S., Marc Shuman, M.D., Lloyd Damon, M.D., James Rubenstein, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1364.
https://doi.org/10.1182/blood.V110.11.1364.1364
Published: 2007
Journal Articles

Identification of CSF Biomarkers for the Diagnosis of CNS Lymphoma.

James L. Rubenstein, MD, PhD, Cigall Kadoch, Jon Karch, BA, Andrew Josephson, MD, Samar Issa, MD, Chris Becker, PhD, Howard Schulman, PhD, Lloyd Damon, MD, Marc A. Shuman, MD, Sushmita Roy, PhD
Journal: Blood
Blood (2006) 108 (11): 2036.
https://doi.org/10.1182/blood.V108.11.2036.2036
Published: 2006
Journal Articles

Gene expression and angiotropism in primary CNS lymphoma

Clinical Trials & Observations
James L. Rubenstein, Jane Fridlyand, Arthur Shen, Ken Aldape, David Ginzinger, Tracy Batchelor, Patrick Treseler, Mitchel Berger, Michael McDermott, Michael Prados, Jon Karch, Craig Okada, William Hyun, Seema Parikh, Chris Haqq, Marc Shuman
Journal: Blood
Blood (2006) 107 (9): 3716–3723.
https://doi.org/10.1182/blood-2005-03-0897
Published: 2006
Includes: Supplemental data